Treatment of ADHD: Guanfacine Extended Release in ADHD

Investigators at Massachusetts General Hospital, Boston, MA, performed a multicenter, 9-week, double-blind, placebo-controlled, dose-optimization study of guanfacine extended release (GXR, <4 mg/d) adjunctive to a long-acting psychostimulant for ADHD continued in 461 subjects.

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: J Gordon Millichap (Yazar), John J Millichap (Yazar)
Materyal Türü: Kitap
Baskı/Yayın Bilgisi: Pediatric Neurology Briefs Publishers, 2014-08-01T00:00:00Z.
Konular:
Online Erişim:Connect to this object online.
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Internet

Connect to this object online.

3rd Floor Main Library

Detaylı Erişim Bilgileri 3rd Floor Main Library
Yer Numarası: A1234.567
Kopya Bilgisi 1 Kütüphanede